Health Care Technology

iTonic

iTonic released FY2025 Q3 earnings on March 30 (EST), actual revenue USD 227.76K, actual EPS USD -0.0896

iTonic released FY2025 Q4 earnings on March 30 (EST), actual revenue USD 227.76K, actual EPS USD -0.0896

iTonic released FY2025 Annual Earnings on March 30 (EST), actual revenue USD 523.03 K, actual EPS USD -0.3178

iTonic released FY2025 9 Months Earnings on March 30 (EST), actual revenue USD 295.27K, actual EPS USD -0.2254

iTonic released FY2025 Q1 earnings on December 16, 2025 (EST), with actual revenue of USD 33.75K and EPS of USD -0.0678

iTonic released FY2024 Q2 earnings on December 16, 2025 (EST), actual revenue USD 105.24K, actual EPS USD -0.0118

iTonic released FY2024 Q1 earnings on December 16 Post-Market (EST), actual revenue USD 105.24 K, actual EPS USD -0.0118

ITOC.US released FY2025 Semi-Annual earnings on December 16 (BJT), actual revenue USD 67.51 K, actual EPS USD -0.1357

iTonic released FY2025 Q2 earnings on December 16 (EST), actual revenue USD 33.75 K, actual EPS USD -0.0678

ITOC.US released FY2024 Semi-Annual earnings on December 16, 2025 (BJT), with actual revenue of USD 210.49K and EPS of USD -0.0237

ITOC.US released FY2023 Q3 earnings on March 20 (BJT), actual revenue USD 180.9 K, actual EPS USD -0.0065

iTonic released FY2024 Q4 earnings on March 20, 2025 (EST), actual revenue USD 118.85K, actual EPS USD -0.0139

ITOC.US released FY2022 Q4 earnings on March 20, 2025 (BJT), actual revenue USD 146.26 K, actual EPS USD 0.0005

iTonic released FY2024 9 Months Earnings on March 20 (EST), actual revenue USD 329.34 K, actual EPS USD -0.0377

iTonic released FY2024 Q3 earnings on March 20, 2025 (EST), actual revenue USD 118.85 K, actual EPS USD -0.0139

iTonic released FY2023 Q4 earnings on March 20, 2025 (EST), actual revenue USD 180.9K, actual EPS USD -0.0065

iTonic released FY2022 Annual Earnings on March 20, 2025 (EST), with actual revenue of USD 679.78 K and EPS of USD 0.0069

ITOC.US released FY2023 Annual Earnings on March 20, 2025 (BJT), with actual revenue of USD 628.59K and EPS of USD -0.0201

iTonic released FY2024 Annual Earnings on March 20 (EST), actual revenue USD 448.2K, actual EPS USD -0.0519

Liminatus Pharma

Agape ATP

Tradr 2X Long QBTS Daily ETF

Defiance Daily Target 2X Long RGTI ETF

NewGenIvf

Tradr 2X Long RGTI Daily ETF

Sunshine Biopharma

Co-Diagnostics

Wheeler Real Estate

Infleqtion

TRVI

ADVB

SCNI

ITOC

EUDA

In Monday's after-market session, several health care stocks experienced notable movements. Gainers included Kala Bio (+7.2% to $0.13), Prothena Corp (+6.39% to $11.48), Revolution Medicines (+6.32% to $140.0), BioAtla (+6.2% to $4.79), Adagio Medical Holdings (+6.05% to $1.22), and Trevi Therapeutics (+4.55% to $14.92). Conversely, Erasca saw a significant decline of 25.0% to $14.37, followed by Advanced Biomed (-6.9% to $5.0), EUDA Health Holdings (-5.99% to $12.09), iTonic Holdings (-5.68% to $0.38), Aspire Biopharma Holdings (-5.43% to $0.23), and Scinai Immunotherapeutics (-5.02% to $0.57).

benzinga_article

Trevi Therapeutics

Advanced Biomed

Scinai Immunotherapeutics

Adagio Medical

Prothena

BioAtla

KALA BIO

Revolution Medicines

Euda Health

Erasca

VG Health

iShares US Healthcare Providers

iShares US Medical Devices

SPDR S&P Health Equip

SPDR S&P Biotech

Direxion S&P Biotech Bull 3X

Health Care Select Sector SPDR

Aspire Biopharma

REVOLUTION MEDICINES INC C/WTS 17/12/2026 (TO PUR COM)

Euda Health - CW22

ASPIRE BIOPHARMA HOLDINGS INC C/WTS 14/02/2030 (TO PUR COM)

12 Health Care Stocks Moving In Monday's After-Market Session

iTonic Holdings shares are trading higher after the company announced it received a 180-day extension to regain Nasdaq compliance.

Nasdaq

SNOA

TVGN

CTXR

In Friday's pre-market session, several health care stocks experienced significant movements. Scinai Immunotherapeutics (NASDAQ:SCNI) surged 145.6% to $1.12, while Organon (NYSE:OGN) rose 28.37% to $11.04. Other gainers included iTonic Holdings (NASDAQ:ITOC) up 21.96%, Tivic Health Systems (NASDAQ:TIVC) up 18.74%, and Addex Therapeutics (NASDAQ:ADXN) up 14.0%. Conversely, Sonoma Pharmaceuticals (NASDAQ:SNOA) fell 26.1% to $1.33, with Citius Pharmaceuticals (NASDAQ:CTXR) down 24.79%. Tevogen Bio Holdings (NASDAQ:TVGN) decreased by 20.83%, and EUDA Health Holdings (NASDAQ:EUDA) fell 14.93%.

Sonoma Pharma

Tevogen Bio

Citius Pharma

Organon

Addex Therapeutics

SPDR S&P Health

iShares US Pharma

ALPS Medical Breakthrough

First Trust NYSE Arca Biotech Index Fd

Invesco Nasdaq Biotechnology ETF

iShares Biotechnology ETF

Invesco Biotechnology & Genome ETF

12 Health Care Stocks Moving In Friday's Pre-Market Session

iTonic Holdings Ltd (ITOC) shares surged 66.42% to $0.50 in after-hours trading after Nasdaq granted a 180-day extension to comply with its minimum bid price requirement. The stock closed at $0.30, down 1.64%, and remains below the $1 threshold needed for compliance. The new deadline is October 19, and failure to comply may lead to delisting. ITOC has a market cap of $5.19 million and has dropped 89.81% over the past year, trading near its annual low.

Fidelity

IREN

Freecast

iTonic Holdings (ITOC) Stock Surges Over 66% After Hours: Why Is It Moving?

YCBD

MEDP

In Thursday's pre-market session, Akanda (NASDAQ:AKAN) saw a significant gain of 49.9%, reaching $15.3, while West Pharmaceutical Services (NYSE:WST) rose by 17.34% to $322.0. Other gainers included cbdMD (AMEX:YCBD) up 16.13%, INVO Fertility (NASDAQ:IVF) up 10.67%, and Dr Reddy's Laboratories (NYSE:RDY) up 7.63%. Conversely, Axe Compute (NASDAQ:AGPU) dropped 23.3%, Altimmune (NASDAQ:ALT) fell 17.3%, and Medpace Holdings (NASDAQ:MEDP) decreased by 17.21%.

cbdMD

Medpace

West Pharmaceutical

Altimmune

Akanda

INVO Fertility

Dr Reddys Laboratories

iShares Genomics Immunology and Healthcare ETF

Ark Genomic Revolution ETF

Proshares Ultra Nasdaq Biotech

iShares Global Healthcare

VanEck Biotech ETF

InspireMD

Axe Compute

Icecure Medical

Silo Pharma

SciSparc

CBDMD INC 8% SERIES A CUM CONVERT PFD STK USD25

12 Health Care Stocks Moving In Thursday's Pre-Market Session

iTonic Holdings Ltd, a healthcare solution provider specializing in brachytherapy treatment planning systems, announced that Nasdaq approved their request for a 180-calendar day extension, until October 19, 2026, to comply with the minimum closing bid price requirement under Nasdaq Listing Rule 5550(a)(2). The company received notification on April 21, 2026, following the expiration of the initial compliance period on April 20, 2026.

Unusual Whales

iTonic Holdings Ltd Granted An Extension of Additional 180-Day by Nasdaq to Regain Compliance with Minimum Bid Price Rule

Rosen Law Firm is investigating potential securities claims for iTonic Holdings Ltd. (NASDAQ: ITOC) due to allegations of misleading business information. Investors who purchased iTonic securities may be eligible for compensation through a class action lawsuit without upfront costs. Interested parties can contact Phillip Kim, Esq. for more information. The firm has a strong track record in securities class actions, having secured significant settlements for investors in the past.

MorningStar

Rosen Law Firm Encourages iTonic Holdings Ltd. Investors to Inquire About Securities Class Action Investigation – ITOC

iTonic(ITOC.US)